My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 9:48 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Adolor Corp
Adolor Corp (ADLR.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
ADLR
on other exchanges
As of 25 Nov 2009
1.50
USD
Price Change
-0.06
Percent Change
-3.85%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Limongelli, John
39
2008
Senior Vice President, General Counsel, Secretary
Salinas, Eliseo
53
2008
Senior Vice President - Research and Development, Chief Medical Officer
Maurer, George
53
2009
Senior Vice President - Manufacturing and Pharmaceutical Technologies
Dougherty, Michael
52
2006
President, Chief Executive Officer, Director
Goddard, Paul
59
2000
Director
Nash, Claude
66
2000
Director
Hager, George
53
2003
Director
Anido, Armando
51
2003
Director
Nickelson, Donald
76
2003
Director
Gemayel, Georges
48
2007
Director
Magni, Guido
55
2008
Director
Webster, Stephen
48
2008
Chief Financial Officer, Senior Vice President - Finance
Madden, David
46
2006
Chairman of the Board
Find out more about ADLR.O
Insider Trading